Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Prostate Cancer Treatment and Research, Ferroptosis and cancer prognosis, and Epigenetics and DNA Methylation.
Methionine orchestrates the metabolism vulnerability in cisplatin resistant bladder cancer microenvironment
Integrative multi-omics and drug–response characterization of patient-derived prostate cancer primary cells
CircDHRS3 inhibits prostate cancer cell proliferation and metastasis through the circDHRS3/miR-421/MEIS2 axis
Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments
PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance
A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer
Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation
Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation
Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer
Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer
PI3Kβ Inhibitor TGX221 Selectively Inhibits Renal Cell Carcinoma Cells with Both VHL and SETD2 mutations and Links Multiple Pathways
Proinflammatory Cytokines in Prostate Cancer Development and Progression Promoted by High-Fat Diet
Diabetes mellitus and prostate cancer risk of different grade or stage: A systematic review and meta-analysis
Comparison of post-operative intravesical recurrence and oncological outcomes after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma
Adrenal myelolipoma: A mingle of progenitor cells?
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4
A novel Germline mutation in <i>HOXB13</i> is associated with prostate cancer risk in Chinese men
Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma